Dec 23rd, 2016
Shkreli: Price Increase Has Stuck, Happy With That
Former Turing Pharmaceuticals CEO Martin Shkreli discusses the controversy surrounding Daraprim pricing and his outlook for the pharmaceutical industry. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)







